Garner Asset Management Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-170
Closed -$3.42K 312
2023
Q4
$3.42K Buy
+170
New +$3.14K ﹤0.01% 300
2022
Q1
Sell
-2,490
Closed -$229K 181
2021
Q4
$229K Hold
2,490
0.09% 165
2021
Q3
$316K Hold
2,490
0.14% 152
2021
Q2
$414K Hold
2,490
0.19% 135
2021
Q1
$453K Sell
2,490
-500
-17% -$116K 0.23% 116
2020
Q4
$598K Hold
2,990
0.33% 99
2020
Q3
$656K Sell
2,990
-100
-3% -$21.2K 0.43% 74
2020
Q2
$590K Sell
3,090
-100
-3% -$17.5K 0.44% 72
2020
Q1
$494K Sell
3,190
-60
-2% -$6.98K 0.44% 75
2019
Q4
$272K Hold
3,250
0.19% 126
2019
Q3
$220K Sell
3,250
-100
-3% -$6.58K 0.16% 132
2019
Q2
$222K Buy
+3,350
New +$195K 0.17% 133
2018
Q4
Sell
-3,450
Closed -$298K 153
2018
Q3
$298K Hold
3,450
0.23% 114
2018
Q2
$200K Buy
+3,450
New +$168K 0.16% 145

Other funds holding TDOC

Garner Asset Management Corp's TDOC Position: Q1 2024 in Review

Garner Asset Management Corp sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 170 shares — an estimated $3.42K sold.

Garner Asset Management Corp first reported a position in TDOC in Q2 2018 and held it in 14 quarters. The position peaked at $656K in Q3 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Garner Asset Management Corp reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Garner Asset Management Corp sold 170 Teladoc Health shares in Q1 2024, an estimated $3.42K.
  • Garner Asset Management Corp first reported a position in Teladoc Health in Q2 2018 and held it in 14 quarters.
  • Garner Asset Management Corp's Teladoc Health position peaked at $656K in Q3 2020.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Garner Asset Management Corp's 13F filing for Q1 2024, filed 16 May 2024.